FAKTOR OPTIONSSCHEIN - INSPIRE MEDICAL SYSTEMS Share Price

Certificat

DE000GQ9N728

Real-time BOERSE MUENCHEN 11:25:09 03/07/2024 BST
16.2 EUR +2.40% Intraday chart for FAKTOR OPTIONSSCHEIN - INSPIRE MEDICAL SYSTEMS
Date Price Change
03/07/24 16.2 +2.40%
02/07/24 15.82 -20.02%
01/07/24 19.78 +7.97%
28/06/24 18.32 -19.01%
27/06/24 22.62 -16.90%

Real-time BOERSE MUENCHEN

Last update July 03, 2024 at 11:25 am

More quotes

Static data

Product typeExotische Produkte
Buy / SellCALL
Underlying INSPIRE MEDICAL SYSTEMS, INC.
Issuer Goldman Sachs
WKN GQ9N72
ISINDE000GQ9N728
Date issued 25/06/2024
Strike 119.3 $
Maturity Unlimited
Parity 0.9 : 1
Emission price 21.65
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 28.76
Lowest since issue 15.82
Spread 1.5
Spread %8.07%

Company Profile

Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire system is the FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. The Company has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sell its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ENT physicians and sleep centers.
Sector
-
More about the company

Ratings for Inspire Medical Systems, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Inspire Medical Systems, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
134.2 USD
Average target price
243.7 USD
Spread / Average Target
+81.55%
Consensus